Physician

Matthew Sand Mosura, MD

According to 2025 Medicare claims, Matthew Mosura, MD (NPI: 1861613291) practices interventional pain management (ipm) in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Bossier, LA. This provider's primary affiliated billing organization is MUSCULOSKELETAL INSTITUTE OF LOUISIANA, L.L.C. (NPI: 1316957012; TIN: 72-0715014) and primary practice location at 71101-4531.

Mosura's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 599 traditional Medicare patients, billed 7,624 HCPCS/CPT codes, and received $475,368 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 6,271 prescription claims across 521 beneficiaries totaling $318,821 in drug costs, led by Belbuca (Buprenorphine Hcl). 2017 DME data shows 22 claims. Open Payments data shows 14 records totaling $369. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$297K$594K2015 Medicare payment: $507,356 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $511,459 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $411,477 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $385,470 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $541,538 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $482,399 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $593,557 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $579,742 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $537,887 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $475,368 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201571314,505$507,356
20167748,996$511,459
20178278,066$411,477
20188657,715$385,470
20198079,177$541,538
20206588,121$482,399
20217049,017$593,557
20226959,054$579,742
20236588,063$537,887
20245997,624$475,368

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$230K$460K2015 Drug cost: $411,975 (USD; Tot_Drug_Cst)2016 Drug cost: $459,775 (USD; Tot_Drug_Cst)2017 Drug cost: $429,539 (USD; Tot_Drug_Cst)2018 Drug cost: $342,611 (USD; Tot_Drug_Cst)2019 Drug cost: $292,172 (USD; Tot_Drug_Cst)2020 Drug cost: $245,273 (USD; Tot_Drug_Cst)2021 Drug cost: $304,909 (USD; Tot_Drug_Cst)2022 Drug cost: $335,835 (USD; Tot_Drug_Cst)2023 Drug cost: $361,520 (USD; Tot_Drug_Cst)2024 Drug cost: $318,821 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153624,519$411,975
20164265,335$459,775
20174435,607$429,539
20184224,828$342,611
20194105,108$292,172
20203934,991$245,273
20214705,612$304,909
20224976,076$335,835
20234956,083$361,520
20245216,271$318,821

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.3K$2.7K2015 Medicare payment: $2,680 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $211 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151155$2,680
2016N/RN/RN/R
2017N/R22$211
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0480Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms251627$111
64483Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level180254$87
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4261,910$78
80307Testing for presence of drug, by chemistry analyzers310943$60
99211Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional2011,002$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl1203,600$90,662
BuprenorphineBuprenorphine2968,727$77,804
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,05026,180$29,905
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,45434,757$26,964
Xtampza ErOxycodone Myristate441,312$22,128

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$369Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Sand Mosura, MD?

Tedicare shows public-source Medicare data for Matthew Sand Mosura, MD (NPI 1861613291), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Sand Mosura, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Sand Mosura, MD?

Matthew Sand Mosura, MD is linked to MUSCULOSKELETAL INSTITUTE OF LOUISIANA, L.L.C. (billing NPI 1316957012) in the available physician profile data.

Does Matthew Sand Mosura, MD have Open Payments data?

Matthew Sand Mosura, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.